IHC and the WHO classification of lymphomas: Cost effective immunohistochemistry using a deductive reasoning "decision tree" approach

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 5, 2009, Pages 366-374

  Taylor, Clive R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Classification of lymphomas; Decision trees; Deductive reasoning; Diagnosis of lympadenopathy; Immunohistochemistry; WHO classification of tumors hematopoeitic and lymphoid tissues

Indexed keywords

B CELL LYMPHOMA; BURKITT LYMPHOMA; CLINICAL PRACTICE; DECISION TREE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FOLLICULAR LYMPHOMA; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH FOLLICLE; LYMPH NODE; LYMPHADENOPATHY; LYMPHOID TISSUE; LYMPHOMA; MANTLE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STANDARD; T CELL LYMPHOMA; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; WORLD HEALTH ORGANIZATION;

COST-BENEFIT ANALYSIS; DECISION TREES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA;

EID: 70349745636     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181af4730     Document Type: Review

References (23)

1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumors of the Haematopoietic and Lymphoid Tissues. Geneva: IARC, WHO Press; 2008.
2. Robb-Smith AHT, Taylor CR. Lymph Node Biopsy. Oxford: Oxford University Press; 1980.
3. Taylor CR. Classification of lymphomas: "new thinking" on old thoughts. Arch Pathol Lab Med. 1978;102:549-554.
4. Lukes RJ, Parker JW, Taylor CR, et al. Immunologic approach to non-Hodgkin's lymphomas and related leukemias. An analysis of the results of multiparameter studies of 425 cases. Semin Hematol. 1978;15:322-351.
5. Taylor CR. Changing concepts in classification of lymphoma. In: Bosman F, van den Tweel J, Taylor CR, eds. Malignant Lymphomas, the Pathophysiology of the Lymphocyte and its Neoplasms. Leiden: Leiden University Press, Leiden; 1980: 175-184.
6. Dunphy CH. Gene expression profiling data in lymphoma and leukemia: a review of the literature and extrapolation of pertinent clinical applications. Arch Pathol. Lab Med. 2006;130:483-520.
7. Higgins RA, Blankenship JE, Kinney MC. Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Arch Pathol Lab Med. 2008;132:441-461. (Pubitemid 351328816)
8. Isaacson PG. Haematopathology practice: the commonest problems encountered in consultation practice. Histopathology. 2007;50: 821-834. (Pubitemid 46850081)
9. Fraga M, Forteza J. Diagnosis of Hodgkin's disease: an update on histopathological and immunophenotypical features. Histology Histopath. 2007;22:923-935. (Pubitemid 47034158)
10. Stein H, Hummel M, Johrens K, et al. Classification and pathogenesis of malignant lymphomas. Internist. 2007;48:351-361.
11. Bazemore AW, Smucker MD. Lymphadenopathy and Malignancy. Am Fam Physician. 2002;66:2103-2110.
12. Lee Y, Terry R, Lukes RJ. Lymph node biopsy for diagnosis: a statistical study. J Surg Oncol. 1980;14:53-60. (Pubitemid 10105739)
13. Wright DH, Addis BJ, Leong ASY. Diagnostic Lymph Node Pathology. Hodder Arnold; 2006.
14. Isaacson P. Lymphoproliferative Diseases. In: Anthony PP, ed. Diagnostic Pitfalls in Histopathology and Cytopathology Practice. London, Greenwich Medical Media; 1998:73-88.
15. Ioachim HL, Medeiros LJ. Lymph Node Pathology. Lymph Node Hyperplasia. Philadelphia, PA: Lipincott Williams and Wilkins; 2008.
16. Knowles DM. Neoplastic Hematopathology. Philadelphia, PA: Lipincott Williams Wilkins; 2001.
17. Weiss L. Lymph Nodes. Cambridge: Cambridge Medicine; 2008.
18. Su W, Yeong KF, Spencer J. Immunohistochemical analysis of human CD5 positive cells: mantle cells and mantle cell lymphoma are not equivalent in terms of CD5 expression. J Clin Pathol. 2000;53:395-397. (Pubitemid 30256910)
19. Taylor CR. Hodgkin's disease is a Non-Hodgkin Lymphoma. Hum Pathol. 2005;36:1-4.
20. Katzenberger AP, Eifert M. Presence of preserved reactive germinal centers in follicular lymphoma is a strong histopathologic indicator of limited disease stage. Am J Surg Pathol. 2005;29: 1661-1664. (Pubitemid 43754488)
21. Sotomayor EA, Shah IM, Sanger WG, Mark HFL. In situ follicular lymphoma with a 14;18 translocation diagnosed by a multimodal approach. Exp Mol Pathol. 2007;83:254-258.
22. Taylor CR, Riley CR. Molecular Morphology of Hodgkin Lymphoma. Appl Immu nohistochem Mol Morph. 2001;9: 187-202.
23. Taylor CR. IHC and the WHO classification of lymphomas: cost effective immunohistochemistry using a deductive reasoning "decision tree" approach. Appl Immunohistochem Mol Morph. 2009;17:366-374.